Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized trial of Ninjin' yoeito in NAFLD patients with fatigue
jRCTs071200113Active, not recruiting
- Sponsor
- Kracie
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ninjinyoeito in metabolic dysfunction-associated steatotic liver disease (MASLD) (2 arms), sponsored by Kracie. Primary endpoint: Primary: Change in QOL and fatigue after 48 weeks. Started Jul 2021; status: active, not recruiting.
02
Drugs
ninjinyoeito
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on jRCTs071200113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071200113.